NCT07288138: A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- State
- Under way
- Phase
- Phase 2
- People
- 160 planned
- Started
- 15 Dec 2025
- Primary completion
- 15 Sep 2027
- Arms
- ECC4703 Low Dose, ECC4703 High Dose
- Results
- None posted
- 15 Dec 2025: Trial started
- 17 Dec 2025: Trial registered